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The development of the complex network of epithelial
tubes that ultimately forms the Drosophila tracheal
system relies on cell migration, cell shape changes,
cell rearrangements, cell differentiation, and branch
fusion [1–3]. Most of these events are controlled by
a combination of distinct transcription factors and
cell-cell signaling molecules, but few proteins that
do not fall within these two functional classes have
been associated with tracheal development. We show
that the MAGUK protein Polychaetoid (Pyd/ZO-1), the
Drosophila homolog of the junctional protein ZO-1
[4], plays a dual role in the formation of tracheal tubes.
pyd/ZO-1 mutant embryos display branch fusion de-
fects due to the lack of reliable determination of the
fusion cell fate. In addition, pyd/ZO-1mutant embryos
show impaired cell intercalation in thin tracheal
branches. Pyd/ZO-1 localizes to the adherens junc-
tions (AJs) in tracheal cells andmight thusplay adirect
role in the regulation of the dynamic state of the AJ
during epithelial remodeling. Our study suggests
that MAGUK proteins might play important roles dur-
ing AJ remodeling in epithelial morphogenesis.
Results and Discussion
polychaetoid Is a trachealess Target Gene, and Its
Product Localizes to the Adherens Junctions
Cell fate determination in the Drosophila tracheal sys-
tem is regulated by the Trachealess (Trh) transcription
factor [5–7]. In order to identify novel Trh target genes,
we performed a comparison of the transcriptional pro-
files of wild-type and loss-of-function trh mutant Dro-
sophila stage 11 embryos using the Affymetrix Gene-
Chip technology. We found the expression of the
polychaetoid (pyd) gene [4, 8] to be downregulated in
a trh mutant background (data not shown). pyd/ZO-1
is expressed in the tracheal placodes of stage 11
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Dr. Bohr-Gasse 7, A-1030 Vienna, Austria.embryos (Figures 1A and 1B, white arrows). Expression
was also observed in the foregut and hindgut (Figures
1A and 1B, black arrows) and in the epidermis. In trhmu-
tant embryos, pyd/ZO-1 transcription was still observed
in the epidermis, the foregut, and the hindgut but was
absent from the tracheal placodes (compare Figures
1C and 1D). pyd/ZO-1 encodes the Drosophila homolog
of the vertebrate cell-cell junction-associated protein
zonula occludens 1 (ZO-1) [4] (Figure 1F) and is a
member of the MAGUK family of proteins (for reviews,
see [9–11]).
MAGUK proteins are known to be incorporated in
macromolecular protein complexes located at the tight
junctions (TJs) in vertebrates. In Drosophila, Pyd/ZO-1
localizes to the adherens junctions (AJs) of the embry-
onic epidermis and the larval imaginal disc epithelium
[12]. We expressed an N-terminal eGFP-tagged full-
length Pyd/ZO-1 protein (Figure 1F) in tracheal cells un-
der the control of thebtl-Gal4 driver and observed a GFP
signal at the level of intercellular AJs of the dorsal trunk
(DT) (Figure 1G) in a mesh-like pattern similar to the
D-a-catenin-GFP (see Figures S1A and S1B in the Sup-
plemental Data available with this article online) and
Shotgun/E-cadherin-GFP (Shg/E-Cad-GFP) fusion con-
structs (Figures S1B and S1D). GFP fluorescence was
also seen in single lines corresponding to the autocellu-
lar AJs of the dorsal branches (DBs) (Figures 1G and 1I;
Figures S1A, S1D, and S1F), the ganglionic branches
(GBs), and the lateral trunk (LT) (Figure 1H; Figures S1A,
S1C, and S1E). Double-labeling experiments showed
a colocalization of the GFP-Pyd fusion construct and
Shg/E-Cad at the AJs in the tracheal system (Figures
S1G–S1L). These results demonstrate that Pyd/ZO-1 is
enriched with Shg/E-Cad and D-a-catenin-GFP at the
AJs of tracheal cells.
Loss-of-Function pyd/ZO-1 Mutants Show Tracheal
Fusion Defects
From a chromosome carrying a pyd/ZO-1 allele called
pydC5 and an unlinked lethal mutation [4, 8] (Figure 1E),
we generated a viable FRT82B, pydC5 recombinant
chromosome. We also tested four transposon inser-
tions in the pyd/ZO-1 genomic region [13]: KG02008,
EY04259, KG00264, and BG02748 (Figure 1E). Staining
for the luminal antigen 2A12 showed that the fusion of
dorsal branches (arrow in Figure 2H) was often compro-
mised in pydC5 (data not shown) and FRT82B, pydC5 ho-
mozygous embryos (Figure 2I); in embryos homozygous
for all transposon insertions (Figure 2J and data not
shown); and in embryos with all possible transhetero-
zygous combinations between KG02008, EY04259,
KG00264, BG02748, and FRT82B, pydC5 (Figures 2K
and 2L and data not shown). Occasionally, nonfused
DBs displayed ectopic terminal branching. Similar fusion
defects were occasionally observed in the LT, although
to a lesser extent (data not shown). Additionally, we
found that GBs, which extend ventrally in wild-type em-
bryos (Figure 2D), showed occasional outgrowth defects
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1225Figure 1. Structure, Localization, and Expres-
sion of the polychaetoid/ZO-1 (pyd/ZO-1)
Gene and Its Protein Product
(A–D) Black arrows: fore- and hindgut; white
arrow: tracheal placode. In all images, ante-
rior is to the left.
(A and B) Lateral (A) and dorsal (B) views of
stage 11 wild-type embryos stained with an
antisense pyd/ZO-1 probe.
(C and D) Lateral views of trh heterozygous
(C) and homozygous (D) stage 11 embryos
stained with an antisense pyd/ZO-1 probe.
(E) Schematic representation of the pyd/ZO-1
genomic locus and transposon insertions
pydC5, KG02008, EY04259, KG00264, and
BG02748.
(F) Protein domain organization of Pyd/ZO-1
(top) and the GFP-Pyd/ZO-1 fusion protein
(bottom). GFP: green fluorescent protein;
PDZ: PSD-95/Dlg/ZO-1; SH3: Src-homology
3; GK: guanylate kinase; PRO-RICH: proline-
rich.
(G–I) Three-dimensional reconstruction of
live embryos expressing GFP-Pyd/ZO-1 un-
der the control of the trachea-specific driver
btl-Gal4. Lateral (G), ventral (H), and dorsal
(I) views are shown. DB: dorsal branch; DT:
dorsal trunk; TC: transverse connective; LT:
lateral trunk; GB: ganglionic branch (see
also Figure S1A).in pyd/ZO-1mutants (Figures 2E and 2F). It was reported
previously that pydC5 is a protein null allele [4]. Consis-
tently, we observed that FRT82B, pydC5 and BG02748
alleles transheterozygous for the Df(3R)p-XT103 defi-
ciency, which uncovers the pyd/ZO-1 locus, did not
cause a more severe disruption of the tracheal system
than homozygous FRT82B, pydC5 or BG02748 (Table
S1), suggesting that these two alleles are strong hypo-
morphic or amorphic mutations.
As the DB fusion-defect phenotype is not fully pene-
trant, we arbitrarily grouped occurring phenotypes in
three categories: only one metamere affected (weak
phenotype), two to four metameres affected (intermedi-
ate phenotype), and five or more metameres affected
(severe phenotype) (Figures 2A–2C). Seventy-four
percent and seventy-six percent of yw and FRT82B,
pydC5/+ heterozygous embryos, respectively, showed
no detectable phenotype, and no embryo with a severe
phenotype was observed (Figure 2G and Table S1). In
contrast to these control embryos, the amount of em-
bryos showing a severe phenotype was significantlyincreased in the different mutants (Figure 2G and Table
S1). Expression of a full-length pyd/ZO-1 cDNA or the
GFP-pyd fusion in the tracheal cells of FRT82B, pydC5
and BG02748 homozygous embryos partially rescued
the phenotype (Figure 2G and Table S1). Altogether,
these results strongly suggest that pyd/ZO-1 is required
for proper fusion of the DBs and, to a lesser extent, the
LT, as well as for proper outgrowth of the GBs. These
phenotypes are due to specific lesions in the pyd/ZO-1
locus, as shown by the rescue experiments.
pyd/ZO-1 Is Required for Fusion- versus
Terminal-Cell Fate Specification
We studied terminal- and fusion-cell fate determination
by analyzing both blistered/Drosophila serum reponse
factor (bs/Dsrf) [14] and escargot (esg) [15, 16] ex-
pression patterns in pyd/ZO-1 loss-of-function mutant
embryos. We found that, instead of a single Bs/Dsrf-
expressing cell at the tip of DBs ([14] and arrowhead in
Figure 2H), some DBs were characterized by the pres-
ence of an ectopic terminal cell in pyd/ZO-1 mutants
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1226Figure 2. pyd/ZO-1 Mutants Display Branch Fusion Defects, Ectopic Terminal Cells, Lack of Fusion Cells, and Ganglionic Branch Defects
(A–C) Dorsal views of stage 16 pyd/ZO-1mutant embryos stained with mAb2A12 (red) and anti-DSRF (green) antibodies and phenotypic cate-
gories with respect to the DB fusion defect detected in weak ([A], one metamere affected), intermediate ([B], two to four metameres affected),
and severe ([C], five or more metameres affected) phenotypes.
(D–F) Ventral views of wild-type (D), EY04259 (E), and FRT82B, pydC5 (F) stage 16 embryos. White arrows: GB outgrowth defects (E and F).
(G) Graphical representation of the distribution of stage 16 embryos in wild-type, weak, intermediate, and severe phenotype categories in wild-
type, BG02748, and FRT82B, pydC5 embryos and in BG02748 and FRT82B, pydC5 embryos expressing either a pyd/ZO-1 or a GFP-pyd/ZO-1
rescue construct under the control of the trachea-specific btl-Gal4 driver.
(H–L) Lateral (H and I) and dorsal (J–L) views of FRT82B, pydC5/+ (H), FRT82B, pydC5 (I), BG02748 (J), FRT82B, pydC5/EY04259 (K), and FRT82B,
pydC5/BG02748 (L) embryos. White arrows: fusion point (H) or fusion defects (J–L). White arrowheads: DSRF-positive terminal cells.
(M and N) Stage 15 (M) and stage 16 (N) escargot-lacZ embryos stained with mAb2A12 (red) and anti-b-galactosidase (green) antibodies. Yellow
arrowheads: Escargot-positive fusion cells; asterisks: Escargot-negative fusion cells.
(O) Stage 16 escargot-lacZ embryos stained with mAb2A12 (blue), anti-DSRF (red), and anti-b-galactosidase (green) antibodies.(arrowheads in Figures 2I–2L). This situation is similar to
the previously reported ectopic expression of acheate
and asense in Drosophila wing imaginal discs of pyd/
ZO-1 mutants, with consequent formation of extra mac-
rochaetes on the adult notum [4, 8]. Using an esg-lacZ
line, we observed that in wild-type embryos (data not
shown) or pydC5 heterozygous embryos (Figure 2M),one single lacZ-positive fusion cell is found at the tip
of each DB [16, 17], whereas in pydC5 homozygous indi-
viduals, anti-b-galactosidase staining was absent in
some DBs that had failed to undergo branch fusion (as-
terisks in Figure 2N). We confirmed that branches that
had not fused showed an excess of terminal cells and
a loss of fusion cells by using the esg-lacZ; pydC5 strain
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tant Clones in the Third-Instar Larval Tracheal
System
(A–L) Bright-field ([A–D] and [I–L]) and fluores-
cent (E–H) micrographs of pyd/ZO-1 mutant
homozygous MARCM clones in the tracheal
system of third-instar larvae. (I), (J), (K), and
(L) are highlights of the insets shown in (A),
(B), (C), and (D), respectively. Asterisks: posi-
tion of the GFP-positive clones affecting the
terminal cell (B) and the fusion cell (C and
D). White arrows: DB fusion point (I and J)
and fusion defects (K and L). White arrow-
heads: ectopic terminal branching (H).
(M) Statistical distribution of wild-type and
pyd/ZO-1 mutant MARCM clone terminal
and fusion cells in DBs showing fusion de-
fects. White bar: FRT82B chromosome
(GFP-labeled terminal cell, n = 2 of 16 cells;
GPF-labeled fusion cell, n = 3 of 21 cells);
black bars: FRT82B, pydC5 chromosome
(GFP-labeled terminal cell, n = 1 of 18 cells;
GPF-labeled fusion cell, n = 12 of 19 cells).
Observed differences are statistically rele-
vant as calculated with a Fisher’s exact test.
Wild-type fusion cells/pyd mutant fusion
cells: *p = 0.0014; pyd mutant terminal cells/
pyd mutant fusion cells: **p = 0.0004.to perform a 2A12/Dsrf/b-galactosidase triple immuno-
staining (Figure 2O). These results suggest that pyd/
ZO-1 is involved in fusion- versus terminal-cell specifica-
tion via the regulation of bs/Dsrf or esg gene expression.
Interestingly, we also identified DBs with a wild-type
Dsrf and Esg pattern (one terminal cell and one fusion
cell), which did not undergo branch fusion (Figure 2O).
Therefore, it appears that the cell fate shift observed in
pyd/ZO-1 mutants does not alone explain all fusion de-
fects, and we cannot exclude a mechanical role of
Pyd/ZO-1 in the branch fusion process itself.
To determine whether pyd/ZO-1 function is required in
the terminal or in the fusion cell, we performed clonal
analysis in mosaic third-instar larvae using the MARCM
system [18]. pyd/ZO-1 mutant clones affecting the ter-
minal cells did not affect branch fusion to a significant
extent (Figures 3B, 3F, 3J, and 3M). However, most
pyd/ZO-1 mutant clones including the fusion cells were
associated with branch fusion defects (Figures 3C, 3D,
3G, 3H, and 3K–3M), whereas only a few DBs display-
ing pyd/ZO-1 mutant fusion cells showed a wild-type
branch fusion pattern (Figure 3M). In some cases, we
observed that pyd/ZO-1 homozygous mutant cells in
the position of the fusion cell displayed ectopic terminal
branches (Figures 3D and 3H), an observation that is
reminiscent of the esg loss-of-function phenotype [16].
We therefore conclude that pyd/ZO-1 acts in the fusion
cell to specify fusion- versus terminal-cell fate.We have observed that overexpression of pyd/ZO-1 in
tracheal cells of wild-type embryos mimics the pyd/
ZO-1 DB fusion-defect phenotype (A.C.J., unpublished
data). Taken together, these results suggest a model in
which Pyd/ZO-1 regulates the subcellular localization
and/or activation of a factor of unknown nature involved
in the regulation of gene expression by either inducing
the fusion-cell fate or repressing the terminal-cell fate
in the fusion cell (Figure S2A).
Several MAGUK proteins are known to be used as
scaffold proteins organizing signaling pathways [19–23]
or influencing gene expression [24, 25] (for review, see
[26–28]). pyd/ZO-1 itself regulates the expression of the
acheate-scute gene complex [4, 8]. Further insights
into the molecular aspects of this regulation will provide
a clearer idea about how Pyd/ZO-1 fulfills its function.
Cell Rearrangement in Unicellular Branches
Is Impaired in pyd/ZO-1 Mutants
As our results indicated that Pyd/ZO-1 localizes to the
AJs of the tracheal system (Figures 1G–1I), we analyzed
the dynamics of tracheal cell rearrangements [29, 30] by
examining the D-a-catenin-GFP pattern in pyd/ZO-1
mutant embryos using confocal live imaging techniques.
In stage 16 wild-type embryos (Figures 4A, 4A0, 4D,
4D0, 4G, and 4G0), the cell rearrangement process is
completed in unicellular branches. Cells are in an end-
to-end configuration, with long lines of autocellular
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1228Figure 4. pyd/ZO-1 Mutant Embryos Show Cell Rearrangement Defects
(A–J) Three-dimensional reconstruction of live embryos expressingD-a-Cat-GFP under the control of the trachea-specific driver btl-Gal4. Lateral
([A–C], [A0], and [B0]), ventral ([D–F], [D0], and [E0]), and dorsal ([G–J], [G0], and [I0]) views of wild-type ([A], [D], [G], and [A0]), FRT82B, pydC5 ([B], [B0],
and [H]), andBG02748 ([C], [E], [E0], [I], and [I0]) mutant embryos andBG02748 embryos expressing theGFP-pyd/ZO-1 rescue construct under the
control of the btl-Gal4 driver (J) are shown. (A0), (B0), (D0), (E0), (G0), and (I0) are magnifications of insets in (A), (B), (D), (E), (G), and (I), respectively.
White arrowheads: intercalation defects.
(K) Statistical distribution of dorsal branches displaying intercalation defects in wild-type (column 1),BG02748mutants (column 2), andBG02748
mutant embryos expressing the GFP-pyd/ZO-1 rescue construct under the control of the btl-Gal4 driver (column 3). Wild-type: n = 0 of 52
branches; BG02748: n = 18 of 51 branches; btl-Gal4/UAS-GFP-pyd; BG02748: n = 0 of 75 branches.
(L and M) Three-dimensional reconstruction of a time-lapse movie showing the AJs of DB cells during intercalation in a heterozygous (L) and
homozygous (M) pydC5 mutant embryo. The AJs were visualized by expressing D-a-Cat-GFP under the control of the trachea-specific driver
btl-Gal4. (For the full movies, see Movies S1 and S2.) Time points (0, 50, and 100 min) are indicated in the bottom left corner of each frame. White
arrowheads: intercalation defects.AJs and very tiny rings of intercellular AJs. In contrast to
these control embryos, large loops of intercellular AJs
remained in fine branches of FRT82B, pydC5 (Figures
4B, 4B0, and 4H); BG02748 (Figures 4C, 4E, 4E0, 4F, 4I,
and 4I0); and KG02008, EY04259, and KG00264 (datanot shown) homozygous embryos, indicating that cell
intercalation was not completed. These cell intercalation
defects were not fully penetrant. In the case ofBG02748,
which is the strongest allele with regard to this intercala-
tion phenotype, we counted that 26% of the DBs were
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type embryos (Figure 4K).
Strikingly, in most cases, DBs with a cell intercalation
phenotype were still able to stretch and eventually
reached the dorsal midline (Figure 4B). Some were
even able to undergo branch fusion (Figures 4H and
4I). These results suggest that branch fusion and branch
stretching are not required for DB cell intercalation and
vice versa. Similar observations were made in the case
of the LT, where loops of D-a-catenin-GFP were still
present between LT cells although adjacent metameres
had undergone fusion (Figure 4E).
As mentioned earlier, we observed that pyd/ZO-1 mu-
tant embryos showed GB outgrowth defects (Figures 2E
and 2F). We also found defective cell intercalation in
GBs, and affected branches were shorter than neighbor-
ing GBs (Figure 4E). Therefore, we propose that, in con-
trast to DBs, proper cell intercalation is necessary for
GBs to adopt an elongated tube shape.
Expression of the GFP-pyd construct in the tracheal
system of BG02748 homozygous embryos allowed a
full rescue of the intercalation phenotype, even though
DB fusion defects were not fully rescued (Figures 4J
and 4K). We performed a live confocal time-lapse analy-
sis and observed that, in contrast to stage 16 hetero-
zygous pydC5 embryos, in which DB cells were inter-
calated and remained so until the end of the analysis
(Figure 4L; see also Movie S1), homozygous pydC5 em-
bryos of the same age showed cell intercalation defects
where loops of D-a-catenin-GFP were interspersed with
autocellular AJs (Figure 4M; see also Movie S2). We con-
clude that the zipping process seems to be stopped or
frozen, leaving pairs of cells in a partially intercalated
state. We did not observe that autocellular AJs con-
verted back into intercellular AJs, which could also have
been a possible explanation for the phenotype. It is very
likely that Pyd/ZO-1 is part of the adhesion E-cadherin/
a-/b-catenin protein complex that governs cell-cell ad-
hesion (Figure S2B).
Altogether, our results suggest a role for pyd/ZO-1 in
facilitating the cell rearrangement process that underlies
the formation of fine, elongated tubes with autocellular
AJs in the tracheal system. This phenotype appears to
be functionally independent from the branch-fusion-
defect phenotype described above.
Conclusions
We have shown that Pyd/ZO-1 plays a dual role during
the morphogenesis of the Drosophila tracheal system
and propose that the transcriptional and mechanistic
roles of pyd/ZO-1 are independent. This suggests that
Pyd/ZO-1 uses distinct partners to achieve its two func-
tions in the tracheal system. This is the first report of an
in vivo analysis of pyd/ZO-1 in a cell biological process,
and Pyd/ZO-1 is the first junction-associated protein de-
scribed to have an effect on cell rearrangements during
tracheal branching morphogenesis.
Experimental Procedures
Drosophila Stocks and Genetics
The Drosophila yw strain was used as a wild-type control. Targeted
gene expression was achieved with the Gal4/UAS system [31]. The
paired-Gal4 strain allows Gal4 expression in seven stripes ofepidermal cells [32]. The btl-Gal4 strain drives Gal4 expression at
high levels in all tracheal cells from stage 10 onward [33] and was
kindly provided by Shigeo Hayashi. The trh3 allele [34] was recom-
bined with paired-Gal4 [32] and UAS-GFP (gift of Konrad Basler).
trh homozygous mutant embryos from the progeny of the cross be-
tween the paired-Gal4 and UAS-GFP strains were sorted using a Le-
ica MZ FLIII stereomicroscope: Only the trh homozygotes are GFP
labeled. The visible GFP pattern in paired-Gal4/UAS-GFP individ-
uals allowed us to accurately select stage 11 embryos. The pydC5 al-
lele, kindly provided by Ruy Ueda, was recombined to a FRT82B
chromosome [35]. KG02008, EY04259, KG00264, and BG02748
transposon insertions were generated in the frame of the P element
screen/gene disruption project of the Bellen/Hoskins/Rubin/Spra-
dling laboratories [13]. The esg-lacZ and shg-GFP fly lines have
been described previously in [36] and [37], respectively. The btl-
Gal4, UAS-D-a-Cat-GFP line has been described in [30].
Cloning
A full-length pyd/ZO-1 cDNA was amplified by PCR from a 4–8 hr
embryonic cDNA library (gift from Nicholas Brown) and cloned into
the Drosophila transformation pUAST vector [31]. The same pyd/
ZO-1 cDNA was cloned in frame with the GFP gene into pEGFP-
N1 (Clontech Laboratories, Inc.), and the fusion construct was fur-
ther subcloned into pUAST.
Whole-Mount In Situ Hybridization and Immunostainings
Embryos were fixed and mRNA was detected by in situ hybridization
to whole-mount embryos as described [38], with minor modifica-
tions. A fragment of the pyd/ZO-1 locus was amplified by PCR
from genomic DNA and used to synthesize an antisense RNA probe.
Embryos were fixed and immunostained as described [39], with
minor modifications. The following antibodies were used: mouse
monoclonal IgM 2A12 antibody (diluted 1:10; kindly provided by
Nipam Patel), mouse monoclonal IgG anti-Dsrf (diluted 1:50; [14]),
rabbit anti-b-galactosidase (diluted 1:500; ICN/Cappel), and anti-
rabbit-Cy3 (1:500; Jackson). To amplify the signal in the case of
2A12 and Dsrf, we used peroxidase-conjugated secondary anti-
bodies followed by biotinylated tyramide (NEN Life Science Prod-
uct), which is recognized by streptavidin-fluorescein or streptavidin-
Texas red (NEN Life Science Product). The anti-Dsrf IgG antibody
was used before the 2A12 IgM antibody to minimize crossreaction.
MARCM Clones
A 70FLP/70FLP; btlenhancer-mRFP1moe, btl-Gal4, UAS-GFP-
actin/CyO; FRT82B, tub-Gal80/TM6c fly strain was used to induce
MARCM clones in the third-instar larval tracheal system as de-
scribed in [40].
Live Imaging and Time-Lapse Confocal Microscopy
Embryos expressing the GFP construct of interest were collected
overnight, dechorionated for 3 min in 3%–4% chlorax, and mounted
in 10S Voltalef oil with the hanging drop method [41]. Images were
collected on a Leica TCS SP2 confocal system with Leica Confocal
Software (version 2.5). For excitation, the 488 nm emission line of an
argon laser was used. Typically, 20–30 focal sections were recov-
ered with a spacing of 0.5–1.5 mm between each focal plane and
averaged 4–6 times. For time lapse, stacks were collected with an
interval of typically 2 min.
Three-Dimensional and Four-Dimensional Reconstructions
Images were deconvoluted with Huygens Essentials (version 2.3.0)
from SVI and subsequently processed with Imaris 4.0.4 software
(Bitplane). Some images were treated with Photoshop (Adobe) to
enhance the contrast.
Supplemental Data
Supplemental Data include two figures, one table, and two movies
and can be found with this article online at http://www.
current-biology.com/cgi/content/full/16/12/1224/DC1/.
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